Aura Biosciences, Inc. AURA Proceeds from issuance of common stock relating to employee stock plans

Proceeds from issuance of common stock relating to employee stock plans at other companies

O'Reilly AutomotiveORLY

$16.61M-33.4%

Boston ScientificBSX

$81M-29.6%

ALH

Alliance Laundry Holdings Inc.ALH

$125K—

KemperKMPR

$800K0.0%

ServiceNowNOW

$153M0.0%

Monolithic Power SystemsMPWR

$5.83M+9.3%

Other financials

Income statement

See full

Operating income-$34.9M-20.1%

Net income-$33.7M-22.6%

EPS (diluted)-$0.50+9.1%

Balance sheet

See full

Cash & equivalents$84.8M+122%

Total debt$17.0M-7.9%

Total equity$107.2M-16.2%

Total assets$137.7M-11.4%

Cash flow

See full

Operating cash flow-$29.9M-28.0%

CapEx$102.0K-45.5%

Free cash flow-$30.0M-27.4%

Valuation

See full

Market cap$709.23M+89.4%

Enterprise value$641.43M+80.8%

Returns & leverage

See full

Return on equity-95.6%+222pp

Debt / equity0.2×0.0×

Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s proceeds from issuance of common stock relating to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aura Biosciences, Inc.'s proceeds from issuance of common stock relating to employee stock plans?: Aura Biosciences, Inc. (AURA) reported proceeds from issuance of common stock relating to employee stock plans of $121K in Q1 2026.
How has Aura Biosciences, Inc.'s proceeds from issuance of common stock relating to employee stock plans changed year-over-year?: Aura Biosciences, Inc.'s proceeds from issuance of common stock relating to employee stock plans increased by 26.0% year-over-year, from $96K to $121K.